Biotech | December 10, 2025
Fermenta Biotech to invest Rs. 110 crore for Dahej plant expansion
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Biocon will acquire all of Viatris’ convertible preferred equity in Biocon Biologics for $400 million in cash and $415 million in newly issued Biocon shares
Captured microbes are then neutralized on engineered microbicidal surfaces
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
The fresh capital will propel Cordance into its first-in-human clinical trial
The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
The viewer aims to help radiologists work smarter, faster, and more collaboratively, while reducing IT complexity and freeing up valuable clinical time
The partnership will enable rapid and reliable product delivery
This is the first and only subcutaneous immune checkpoint inhibitor available in Europe
Subscribe To Our Newsletter & Stay Updated
